Literature DB >> 27556005

Pathological and Topographical Classification of Craniopharyngiomas: A Literature Review.

James Lubuulwa1, Ting Lei1.   

Abstract

Craniopharyngiomas (CPs) are clinically relevant tumors of the sellar region and are associated with high morbidity and occasional mortality. There are two different subtypes of CPs that differ clinically and pathologically: adamantinomatous CP and papillary CP. The differential diagnosis is still challenging even with developments in preoperative imaging as several tumors of the sellar/parasellar region share a continuum of clinical characteristics and imaging similarities. Several topographical classifications of CPs have been mentioned in literature, but to date, there has not been a consensus on a standard reference classification system and there is need to a develop such a model.

Entities:  

Keywords:  classification; craniopharyngioma; pathological features; topography

Year:  2016        PMID: 27556005      PMCID: PMC4993606          DOI: 10.1055/s-0036-1588060

Source DB:  PubMed          Journal:  J Neurol Surg Rep        ISSN: 2193-6358


Introduction

Craniopharyngiomas (CPs) are tumors of the sellar and parasellar region and constitute approximately 3% of all intracranial tumors. They are the most common form of nonneuroepithelial neoplasm in pediatric population.1 2 They originate from epithelial remnants anywhere along the obscured craniopharyngeal duct from Rathke's cleft to the floor of the third ventricle.3 4 5 Though classified by World Health Organization as grade 1 tumors,6 there have only been rare reports of malignancy transformation.7 8 9 CPs can cause significant morbidity due to their intimate involvement and mass effect on surrounding structures. Treatment is mainly through surgical resection. Several surgical approaches have been developed depending on topographical location of the tumor,1 4 10 11 12 and post neuroendoscopy radiotherapy,13 Gamma Knife surgery,14 15 and occasional use of Ommaya reservoir placement,16 17 proton beam therapy,18 19 and intracavitary β-irradiation20 21 have been reported in literature. In this parochial literature review, we focus on the pathological classification and topographical location of CPs, highlighting the differences in two CP subtypes, their clinical presentation, imaging characterization, and the salient pathological and topographical location, and, finally, briefly discuss the differential diagnosis of CPs. For more specific clinical and pathological studies on classification of CPs, other published reviews are recommended.22 23 24 25 26 27

Classification According to Tumor Pathology

There are two different subtypes of CPs that differ clinically and pathologically: adamantinomatous CP (ACP) and papillary CP (PCP). The adamantinomatous variant occurs predominantly in the pediatric population, whereas the papillary variant is seen mostly among adults. The ACPs are much more common than PCP (9:1) and are pathologically distinct.26 ACPs are composed of cystic “motor oil-like” component and solid components and frequently contain calcifications that are readily identifiable on neuroimaging. Histologically, they contain nodules of wet keratin, a palisading basal layer of cells, surrounding gliosis, and profuse Rosenthal fiber formation. In contrast, PCPs are rarely calcified, mostly solid, and better circumscribed, and, if cystic, contents are clear. Müller postulated that PCPs are caused by metaplasia of the adenohypophyseal cells in the pars tuberalis of the adenohypophysis, leading to the formation of squamous cell nests.27 Histologically, they consist of mature squamous epithelium and pseudopapillae with no stellate reticulum or ghost cells. Immunohistochemically, a study by Esheba and Hassan demonstrated that cytoplasm/nuclear β-catenin accumulation as an exclusive characteristic hallmark that can used as a reliable marker for distinguishing between ACP and PCP.23 However, there exist some overlapping features between the two subtypes that led to the hypothesis that CPs fall on a histopathological continuum with other cystic epithelial sellar lesions.26 Crotty et al found no significant differences between the two CP subtypes with respect to respectability, efficacy if radiation therapy, and overall survival.28 The salient features of these tumors are summarized in Tables 1 and 2.
Table 1

Comparison of clinical and imaging features of adamantinomatous and papillary craniopharyngiomas

FeatureAdamantinomatous craniopharyngiomaPapillary craniopharyngioma
Incidence, %2 9010
Age28 Bimodal, peak incidences 1–5 y and 50–60 yAlmost exclusively adult51
Sex2 52 No gender preference observedNo gender preference observed
Visual disturbances42 FrequentFrequent
Hypothalamic disturbances27 PossibleFrequent
High ICP symptoms27 39 UsualFrequent
Endocrine disturbances28 FrequentUnusual
Headache27 FrequentFrequent
Mental disturbancesFrequentunusual
Ataxia23
Imaging characteristics44
General imaging featuresSupra- and intrasellar, multilobulated and multicystic massUsually suprasellar, mostly solid and spherical mass
MRIT1: solid regions are hypo- or isointense, cystic regions are hyperintenseStrong heterogeneous enhancementHyperintense on T2T1: hypointense; cystic regions, if present, are hypointenseModerate homogenous enhancementHyperintense on T2
CT53 Solid regions and cyst wall enhancementCalcifications visibleContrast enhancing with no calcifications

Abbreviations: CT, computed tomography; ICP, intracranial pressure; MRI, magnetic resonance imaging.

Table 2

Comparison of pathological features of adamantinomatous and papillary craniopharyngiomas

FeaturesAdamantinomatous craniopharyngiomaPapillary craniopharyngioma
Pathological features
Tumor originAlong pituitary stalkInfundibulum and TVF
Main locationSuprasellar 75%, Intrasellar 20%Infundibulum and third ventricle
Third ventricle invasion39 54 In 50%In > 90%
Lesion covered by sellar diaphragmGenerally Only in infradiaphragmatic CPsExceptionally
Tumor size55 3–6 cm at diagnosis2–3 cm at diagnosis
Tumor shapeMultilobulated or elliptical in 85%Rounded or spherical in 85%
Tumor consistency44 Solid-cystic multilocular in 80%Unilocular cyst or pure solid in (50%)
Hemorrhagic fluid contentFrequentExceptional
Macroscopic features
BoundaryLobular with sharp, irregular interface, adherent to surrounding structures, invasiveTight to chiasm, vessels stalk, and TVFEncapsulated, discrete, often solid; usually no adherence to surrounding structures, exceptionally tight to infundibulum
CystsCyst contents have dark, “motor oil-like” appearance with cholesterol crystals; leakage can result in chemical meningitisWhen cystic, contents are clear
Cystic degenerationIn >90%In unilocular cysts
CalcificationsIn 90% of children and 40% of adultsExceptional
Histopathological features and immunohistochemical expression23
ArchitectureMulticystic, well circumscribed, but with finger-like protrusions into palisading epitheliumDiscrete, encapsulated, often solid
Cellular compositionPeripheral palisading epitheliumStellate reticulum comprising low aggregates of stellate cellsNodules containing anuclear “ghost cells”/wet keratinEpithelial whorls with nuclear β-catenin expressionSquamous and well-differentiated, nonkeratinizing epitheliumFibrovascular core, no stellate reticulumPseudopapillae resulting from epithelial dehiscence, no “ghost cells”/wet keratinNo nuclear β-catenin translocation
Wnt pathway26 Mutations in CTNNB1 at SS3, S37, S45, and T4122 No BRAF p.Val600Glu mutationsNo mutations found in CTNNB1 Recently, overactivating mutations in BRAF p.Val600Glu have been described in association with PCP56
Odontogenic featuresEnamelin, amelogenin, and enamelysin expressedOdontogenic markers not expressed
β-catenin23 Present (cellular and nuclear membrane)Only present in cellular membrane
EGFRCan be present or absentCan be present or absent
ErbB2Can be present or absentCan be present or absent
p63Present in nuclei of basal layer cells and whorl-like areasPresent, restricted to lower third of stratified epithelial cells
Other featuresPiloid gliosis common in peritumoral brainEncasement of blood vesselsChronic inflammation Xanthogranulomatous reaction, occasional ossificationScant goblet/ciliated cells in cyst liningResembling Rathke's cleft cyst; occasionally small, collagenous whorls

Abbreviations: CPs, craniopharyngiomas; EGFR, epidermal growth factor receptor; PCP, papillary craniopharyngioma; TVF, third ventricle floor.

Abbreviations: CT, computed tomography; ICP, intracranial pressure; MRI, magnetic resonance imaging. Abbreviations: CPs, craniopharyngiomas; EGFR, epidermal growth factor receptor; PCP, papillary craniopharyngioma; TVF, third ventricle floor.

Classification According to Tumor Topography

Craniopharyngiomas can arise anywhere along the craniopharyngeal canal, although majorities arise in the sella/parasellar region. Because of their benign nature, they grow silently and are usually present clinically when they are already large with extension into the surrounding sellar region, usually adhering and compressing vital neurologic structures within their vicinity, consequently causing neurologic signs and symptoms. The majority of CPs have suprasellar and supra–intrasellar components, whereas strictly intrasellar CPs are the least common. Furthermore, ectopic and fetal CPs add to the continuum of possible locations of CPs. Several authors have reported primary ectopic CPs in various locations of the cranium: temporal lobe,29 frontotemporal lobe,3 extracranial infrasellar,30 cerebellopontine angle,31 ethmoid sinus,32 and petroclival.33 However, there is no consensus for the mechanism for ectopic occurrence. Theories have been described that stipulate contamination with tumor cells along the surgical tract and vertical spread via cerebrospinal fluid ,3 but more important is the embryogenical theory that CPs may arise from any location along the craniopharyngeal duct. Fetal ACPs have been reported in utero by several authors.34 35 36 37 Kostadinov et al reported an echodense structure at the intracranial midline with an irregular outline measuring 3.1 × 2.69 cm, which displaced the lateral ventricles and choroid plexus detected by prenatal ultrasound and further histology studies of the fetus specimen revealed an ACP. In the same report, they suggested that CP account for approximately 11% of fetal tumors.37 Various grading systems have been suggested by several authors to aid in planning of surgical route either from preoperative images of MRI scans or based on intraoperative views of the anatomical structures involved with or surrounding the tumor.4 Pascual et al reported no significant relation between age and CP topography38 and noted significant association between topography and occurrence of postoperative hypothalamic damage and a strong relation between CP location, and the type of surgical approach and degree of tumor removal. Several authors have reported cases where a mistaken surgical approach was used due to topographical misdiagnosis of the location of CP despite the use of magnetic resonance (MR) images.39 40 41 It is important to consider each case on an individual basis as the imaging characteristics of each pathology and individual anatomical variation strongly influence whether a lesion is treated via a particular approach. Although there has been no consensus on a single standard classification system, several authors have attempted to topographically grade CPs according to preoperative MR images and/or with intraoperative findings. Table 3 summarizes some of the most notable classification systems from studied literature.
Table 3

Summary of topographical classification of craniopharyngiomas from published literature

AuthorsYearBasis of classificationClassification system
Yasargil et al57 1990Relation with diaphragmPurely intrasellar–infradiaphragmaticIntra- and suprasellar, infra- and supradiaphragmaticSupradiaphragmatic parachiasmatic, extraventricularIntra- and extraventricularParaventricular in respect to the third ventriclePurely intraventricular
Hoffman1 1994Relation with ventriclePreventricularSubventricularRetrochiasmaticIntraventricular
Samii and Tatagiba58 1997Tumor extensionI: intrasellar or infradiaphragmII: occupying the cistern with/without an intrasellar componentIII: lower half of the third ventricleIV: upper half of the third ventricleV: reaching the septum pellucidum or lateral ventricles
Kassam et al59 2008Relation with stalkPreinfundibularTransinfundibularRetroinfundibularIsolated intraventricular
Pascual et al39 2004Relation with third ventricleSuprasellar tumor pushing the intact third ventricle floor upwardSuprasellar mass breaking through the third ventricle floor and invading the third ventricle cavityIntraventricular mass within the third ventricle cavity and floor, the latter being replaced by the tumorIntraventricular mass completely located within the third ventricle cavity and with the intact floor lying below its inferior surface
Qi et al60 2011Growth pattern of arachnoid envelope around the stalkInfradiaphragmaticExtra-arachnoidalIntra-arachnoidalSubarachnoidal
Fatemi et al61 2009Anatomic extension of tumorRetrochiasmalSellar and suprasellarCavernous sinus invasionFar lateral extension
Jeswani et al42 2016Endoscopic view of InfundibularInfundibular IInfundibular IIInfundibular III
Matsuo et al62 2014Anatomic association between CP and sellar diaphragm, hypophyseal stalk, and optic nerveRelation with diaphragm Subdiaphragmatic (complete, incomplete) Supradiaphragmatic
Relation with hypophyseal stalk Preinfundibular lateroinfundibular retroinfundibular transinfundibular
Relation with optic nerve Prechiasmatic type Retrochiasmatic type Other (pure intrasellar)Tumor extension Third ventricle Interpeduncular cistern Prepontine cistern Frontal base Cavernous sinusSphenous sinus Sellar type Presellar type Concha type

Differential Diagnosis with Other Tumors of Sellar Region

The differential diagnosis in pathology of sellar masses includes hypothalamic glioma, optic glioma, Langerhans cell histiocytosis, Rathke's cleft cyst, xanthogranuloma, intracranial germinoma, epidermoid tumor, thrombosis of arachnoid cysts, colloidal cyst of third ventricle, pituitary adenoma, an aneurysm, and rare inflammatory variations. Clinically, it is not easy to distinguish because patients with these tumors usually present with nonspecific features such as headache, hypopituitarism, or visual disturbances.39 42 43 On the contrary, Choi et al found that despite the characteristic MR imaging (MRI) findings of the most common sellar region tumors including pituitary adenoma, CPs, and Rathke's cleft cyst, which are well known and significantly distinct to each tumor, it is still challenging to arrive at a differential diagnosis of these tumors,44 although their study demonstrated that tumor characteristics and enhancement patterns could be accurately used in the diagnostic flowchart generated to differentiate these three tumors. The introduction of new technologies, such as the recently developed intraoperative high-field MRI with microscope-based neuronavigation45 46 47 and brain perfusion imaging of CPs by transcranial duplex sonography,48 might lead to a more advanced way of developing a preoperative–intraoperative basis for a standard topographical classification. Immunohistochemically, CP is positive for pancytokeratin but negative for CK28 or CK20, which is exclusively expressed in Rathke's cyst, yet another marker for differential diagnosis for CP.49 Additionally, Kim et al recently reported a BRAF V600E mutation as a useful marker in differentiating Rathke's cleft cyst with squamous metaplasia from PCP.50 Scagliotti et al demonstrated that ACPs are devoid of terminally differentiated pituitary hormone producing cells, which aid in differential diagnosis from other pituitary or sellar region tumors.25

Conclusion

The topographical classification of these subtypes is not purely distinct compared with other tumors of the sellar region, and in as much as it aids in the surgical approach, it has not fully been beneficial in the differential diagnosis from other tumors, with histopathological immunostaining remaining the main stay for confirming a diagnosis of CP. To date, no standardized topographical classification system has been agreed among neuroradiologists and surgeons, and further studies are necessary to design a clinical-based classification system, which could aid in the surgical planning for determining tumor extent for surgery and radiotherapy, as well as posttherapy monitoring.
  62 in total

Review 1.  Intraventricular craniopharyngiomas: topographical classification and surgical approach selection based on an extensive overview.

Authors:  J M Pascual; F González-Llanos; L Barrios; J M Roda
Journal:  Acta Neurochir (Wien)       Date:  2004-06-07       Impact factor: 2.216

Review 2.  Fetal craniopharyngioma: management, postmortem diagnosis, and literature review of an intracranial tumor detected in utero.

Authors:  Stefan Kostadinov; Corey L Hanley; Terakeith Lertsburapa; Barbara O'Brien; Mai He
Journal:  Pediatr Dev Pathol       Date:  2014-07-14

3.  Staged use of the transsphenoidal approach to resect superior third ventricular craniopharyngiomas.

Authors:  J R Coppens; W T Couldwell
Journal:  Minim Invasive Neurosurg       Date:  2010-04-07

4.  Intraventricular craniopharyngioma: a long-term follow-up of six cases.

Authors:  M J Davies; T T King; K A Metcalfe; J P Monson
Journal:  Br J Neurosurg       Date:  1997-12       Impact factor: 1.596

Review 5.  The supraorbital endoscopic approach for tumors.

Authors:  David A Wilson; Huy Duong; Charles Teo; Daniel F Kelly
Journal:  World Neurosurg       Date:  2014-12       Impact factor: 2.104

6.  Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients.

Authors:  M G Yaşargil; M Curcic; M Kis; G Siegenthaler; P J Teddy; P Roth
Journal:  J Neurosurg       Date:  1990-07       Impact factor: 5.115

7.  Pituitary adenoma, craniopharyngioma, and Rathke cleft cyst involving both intrasellar and suprasellar regions: differentiation using MRI.

Authors:  S H Choi; B J Kwon; D G Na; J-H Kim; M H Han; K-H Chang
Journal:  Clin Radiol       Date:  2007-02-26       Impact factor: 2.350

Review 8.  Molecular oncogenesis of craniopharyngioma: current and future strategies for the development of targeted therapies.

Authors:  Ibrahim Hussain; Jean Anderson Eloy; Peter W Carmel; James K Liu
Journal:  J Neurosurg       Date:  2013-04-05       Impact factor: 5.115

9.  Stereotactic intracavitary brachytherapy with P-32 for cystic craniopharyngiomas in children.

Authors:  Mohammad Maarouf; Faycal El Majdoub; Manuel Fuetsch; Mauritius Hoevels; Ralph Lehrke; Frank Berthold; Jürgen Voges; Volker Sturm
Journal:  Strahlenther Onkol       Date:  2015-11-05       Impact factor: 3.621

10.  Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas.

Authors:  Priscilla K Brastianos; Amaro Taylor-Weiner; Peter E Manley; Robert T Jones; Dora Dias-Santagata; Aaron R Thorner; Michael S Lawrence; Fausto J Rodriguez; Lindsay A Bernardo; Laura Schubert; Ashwini Sunkavalli; Nick Shillingford; Monica L Calicchio; Hart G W Lidov; Hala Taha; Maria Martinez-Lage; Mariarita Santi; Phillip B Storm; John Y K Lee; James N Palmer; Nithin D Adappa; R Michael Scott; Ian F Dunn; Edward R Laws; Chip Stewart; Keith L Ligon; Mai P Hoang; Paul Van Hummelen; William C Hahn; David N Louis; Adam C Resnick; Mark W Kieran; Gad Getz; Sandro Santagata
Journal:  Nat Genet       Date:  2014-01-12       Impact factor: 38.330

View more
  10 in total

1.  Topographic Diagnosis of Craniopharyngiomas: The Accuracy of MRI Findings Observed on Conventional T1 and T2 Images.

Authors:  R Prieto; J M Pascual; L Barrios
Journal:  AJNR Am J Neuroradiol       Date:  2017-09-21       Impact factor: 3.825

2.  Clinical impact of craniopharyngioma classification based on location origin: a multicenter retrospective study.

Authors:  Wenfu Hu; Binghui Qiu; Fen Mei; Jian Mao; Lizhi Zhou; Fan Liu; Jun Fan; Yi Liu; Ge Wen; Songtao Qi; Yun Bao; Jun Pan
Journal:  Ann Transl Med       Date:  2021-07

3.  A Rare Case of Craniopharyngioma in the Temporal Lobe.

Authors:  Sasan Razmjoo; Seyed Nematollah Jazayeri; Mohammad Bahadoram; Maedeh Barahman
Journal:  Case Rep Neurol Med       Date:  2017-12-26

4.  A novel endoscopic classification for craniopharyngioma based on its origin.

Authors:  Bin Tang; Shen Hao Xie; Li Min Xiao; Guan Lin Huang; Zhi Gang Wang; Le Yang; Xuan Yong Yang; Shan Xu; Ye Yuan Chen; Yu Qiang Ji; Er Ming Zeng; Tao Hong
Journal:  Sci Rep       Date:  2018-07-05       Impact factor: 4.379

5.  Chemical meningitis in children as a risk factor following craniopharyngioma resection - a case report.

Authors:  Magdalena Chrościńska-Krawczyk; Ewa Zienkiewicz; Arkadiusz Podkowiński; Maria Klatka
Journal:  BMC Neurol       Date:  2020-02-15       Impact factor: 2.474

6.  Risk Factors for Hypothalamic Obesity in Patients With Adult-Onset Craniopharyngioma: A Consecutive Series of 120 Cases.

Authors:  Wei Wu; Quanya Sun; Xiaoming Zhu; Boni Xiang; Qiongyue Zhang; Qing Miao; Yongfei Wang; Yiming Li; Hongying Ye
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-28       Impact factor: 5.555

7.  Reinvestigating Tumor-Ventricle Relationship of Craniopharyngiomas With Predominantly Ventricular Involvement: An Endoscopic Endonasal Series Based on Histopathological Assessment.

Authors:  Jun Fan; Yi Liu; Chaohu Wang; Zhanpeng Feng; Jun Pan; Yuping Peng; Junxiang Peng; Yun Bao; Jing Nie; Binghui Qiu; Songtao Qi
Journal:  Front Oncol       Date:  2021-12-03       Impact factor: 6.244

8.  Papillary craniopharyngioma in a patient following resection of nonfunctioning pituitary adenoma: illustrative case.

Authors:  David J Park; Akash Mishra; Danielle Golub; Jian Y Li; Karen S Black; Michael Schulder
Journal:  J Neurosurg Case Lessons       Date:  2021-01-11

9.  Hypothalamic injury patterns after resection of craniopharyngiomas and correlation to tumor origin: A study based on endoscopic observation.

Authors:  Le Yang; ShenHao Xie; Bin Tang; Xiao Wu; ZhiGao Tong; Chao Fang; Han Ding; YouYuan Bao; SuYue Zheng; Tao Hong
Journal:  Cancer Med       Date:  2020-11-03       Impact factor: 4.452

Review 10.  Typical Pediatric Brain Tumors Occurring in Adults-Differences in Management and Outcome.

Authors:  Ladina Greuter; Raphael Guzman; Jehuda Soleman
Journal:  Biomedicines       Date:  2021-03-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.